CELU Chart
About

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 36.05M
Enterprise Value 102.05M Income -80.65M Sales 40.58M
Book/sh -0.71 Cash/sh 0.00 Dividend Yield —
Payout 0.00% Employees 123 IPO —
P/E — Forward P/E -2.19 PEG —
P/S 0.89 P/B -1.76 P/C —
EV/EBITDA -2.47 EV/Sales 2.52 Quick Ratio 0.10
Current Ratio 0.16 Debt/Eq — LT Debt/Eq —
EPS (ttm) -3.33 EPS next Y -0.57 EPS Growth —
Revenue Growth -43.20% Earnings 2025-08-18 16:00 ROA -25.03%
ROE — ROIC — Gross Margin 50.61%
Oper. Margin -243.17% Profit Margin -198.75% Shs Outstand 28.84M
Shs Float 18.07M Short Float 7.45% Short Ratio 10.80
Short Interest — 52W High 4.35 52W Low 1.00
Beta 0.80 Avg Volume 55.71K Volume 53.51K
Target Price — Recom None Prev Close $1.31
Price $1.25 Change -4.58%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.25
Latest analyst target
3. DCF / Fair value
$7.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.25
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-09-09 up WBB Securities Hold → Buy $6
2025-08-18 init WBB Securities — → Speculative Buy $6
Insider Transactions
Date Shares Value Url Text Insider Position Transaction Start Date Ownership
0 30000 — — Stock Award(Grant) at price 0.00 per share. PARKS DIANE L. Director — 2026-01-12 00:00:00 D
1 20385 — — Stock Award(Grant) at price 0.00 per share. DIAMANDIS PETER Director — 2026-01-12 00:00:00 D
2 19231 — — Stock Award(Grant) at price 0.00 per share. LING GEOFFREY M. D. Director — 2026-01-12 00:00:00 D
3 28847 — — Stock Award(Grant) at price 0.00 per share. LEVIEN VINCENT Director — 2026-01-12 00:00:00 D
4 125000 — — Stock Award(Grant) at price 0.00 per share. PARKS DIANE L. Director — 2025-12-29 00:00:00 D
5 125000 — — Stock Award(Grant) at price 0.00 per share. DIAMANDIS PETER Director — 2025-12-29 00:00:00 D
6 125000 — — Stock Award(Grant) at price 0.00 per share. LING GEOFFREY M. D. Director — 2025-12-29 00:00:00 D
7 125000 — — Stock Award(Grant) at price 0.00 per share. LEVIEN VINCENT Director — 2025-12-29 00:00:00 D
8 67416 — — Stock Award(Grant) at price 0.00 per share. PARKS DIANE L. Director — 2025-12-19 00:00:00 D
9 67416 — — Stock Award(Grant) at price 0.00 per share. DIAMANDIS PETER Director — 2025-12-19 00:00:00 D
Financials
Line Item2024-12-312023-12-312022-12-312021-12-31
TaxEffectOfUnusualItems0.000.000.000.00
TaxRateForCalcs0.000.000.000.00
NormalizedEBITDA-40.39M-74.30M-141.13M-142.74M
TotalUnusualItems-3.32M-109.64M164.78M54.63M
TotalUnusualItemsExcludingGoodwill-3.32M-109.64M164.78M54.63M
NetIncomeFromContinuingOperationNetMinorityInterest-57.89M-196.29M14.19M-100.12M
ReconciledDepreciation7.92M9.32M9.44M8.82M
ReconciledCostOfRevenue8.82M8.88M12.42M3.03M
EBITDA-43.71M-183.95M23.64M-88.11M
EBIT-51.63M-193.27M14.21M-96.93M
NetInterestIncome-5.93M-2.69M365.00K-2.84M
InterestExpense6.26M3.02M0.003.17M
InterestIncome331.00K320.00K365.00K332.00K
NormalizedIncome-54.58M-86.65M-150.58M-154.75M
NetIncomeFromContinuingAndDiscontinuedOperation-57.89M-196.29M14.19M-100.12M
TotalExpenses92.77M99.25M166.24M171.54M
TotalOperatingIncomeAsReported-38.36M-192.29M-25.60M-109.06M
DilutedAverageShares21.89M17.81M14.98M6.71M
BasicAverageShares21.89M17.81M13.99M6.71M
DilutedEPS-2.64-11.020.95-14.90
BasicEPS-2.64-11.021.01-14.90
DilutedNIAvailtoComStockholders-57.89M-196.29M14.19M-100.12M
NetIncomeCommonStockholders-57.89M-196.29M14.19M-100.12M
NetIncome-57.89M-196.29M14.19M-100.12M
NetIncomeIncludingNoncontrollingInterests-57.89M-196.29M14.19M-100.12M
NetIncomeContinuousOperations-57.89M-196.29M14.19M-100.12M
TaxProvision0.0010.00K13.00K20.00K
PretaxIncome-57.89M-196.28M14.21M-100.10M
OtherIncomeExpense-13.41M-117.11M162.11M52.95M
OtherNonOperatingIncomeExpenses-10.09M-7.47M-2.67M-1.68M
SpecialIncomeCharges-3.71M-115.81M122.67M41.15M
GainOnSaleOfBusiness0.00
OtherSpecialCharges3.91M
WriteOff0.00107.80M0.00
ImpairmentOfCapitalAssets0.00112.35M3.61M0.00
RestructuringAndMergernAcquisition-193.00K-104.34M-126.28M-41.15M
GainOnSaleOfSecurity398.00K6.16M42.11M13.48M
NetNonOperatingInterestIncomeExpense-5.93M-2.69M365.00K-2.84M
InterestExpenseNonOperating6.26M3.02M0.003.17M
InterestIncomeNonOperating331.00K320.00K365.00K332.00K
OperatingIncome-38.55M-76.48M-148.27M-150.20M
OperatingExpense77.78M83.23M146.58M161.89M
DepreciationAmortizationDepletionIncomeStatement1.75M2.19M2.19M2.19M
DepreciationAndAmortizationInIncomeStatement1.75M2.19M2.19M2.19M
Amortization1.75M2.19M2.19M2.19M
AmortizationOfIntangiblesIncomeStatement1.75M2.19M2.19M2.19M
ResearchAndDevelopment17.39M30.46M78.36M88.35M
SellingGeneralAndAdministration58.64M50.58M66.02M71.34M
GrossProfit39.23M6.75M-1.69M11.68M
CostOfRevenue14.99M16.02M19.66M9.65M
TotalRevenue54.22M22.77M17.98M21.34M
OperatingRevenue54.22M22.77M17.98M21.34M
Line Item2023-12-31
TreasurySharesNumber0.00
OrdinarySharesNumber22.55M19.38M14.89M12.43M
ShareIssued22.55M19.38M14.89M12.43M
NetDebt41.55M39.01M23.64M
TotalDebt68.84M65.42M65.59M31.14M
TangibleBookValue-7.76M22.61M-41.79M-147.07M
InvestedCapital51.12M80.20M236.50M99.42M
WorkingCapital-33.12M-47.51M-28.59M32.88M
NetTangibleAssets-7.76M22.61M-41.79M-147.07M
CapitalLeaseObligations26.55M26.18M27.98M31.14M
CommonStockEquity8.84M40.96M198.90M99.42M
TotalCapitalization44.76M40.96M198.90M99.42M
TotalEquityGrossMinorityInterest8.84M40.96M198.90M99.42M
StockholdersEquity8.84M40.96M198.90M99.42M
GainsLossesNotAffectingRetainedEarnings-5.00K0.009.00K0.00
OtherEquityAdjustments-5.00K9.00K
TreasuryStock0.00
RetainedEarnings-899.68M-841.79M-645.50M-663.68M
AdditionalPaidInCapital908.52M882.73M844.37M763.09M
CapitalStock2.00K19.00K15.00K12.00K
CommonStock2.00K19.00K15.00K12.00K
PreferredStock0.000.000.000.00
TotalLiabilitiesNetMinorityInterest123.84M102.93M202.16M314.71M
TotalNonCurrentLiabilitiesNetMinorityInterest70.17M35.63M140.08M288.49M
OtherNonCurrentLiabilities1.69M1.90M106.27M232.56M
PreferredSecuritiesOutsideStockEquity0.00
DerivativeProductLiabilities3.26M4.36M3.60M25.96M
NonCurrentDeferredLiabilities2.73M3.19M2.23M1.88M
NonCurrentDeferredRevenue2.72M3.19M2.22M1.87M
NonCurrentDeferredTaxesLiabilities9.00K9.00K9.00K10.00K
LongTermDebtAndCapitalLeaseObligation62.48M26.18M27.98M28.09M
LongTermCapitalLeaseObligation26.55M26.18M27.98M28.09M
LongTermDebt35.93M
CurrentLiabilities53.68M67.30M62.09M26.23M
OtherCurrentLiabilities1.60M2.45M2.63M4.32M
CurrentDeferredLiabilities3.53M2.83M2.27M2.20M
CurrentDeferredRevenue3.53M2.83M2.27M2.20M
CurrentDebtAndCapitalLeaseObligation6.36M39.24M37.60M3.05M
CurrentCapitalLeaseObligation0.003.05M
CurrentDebt6.36M39.24M37.60M
OtherCurrentBorrowings6.36M39.24M37.60M
PayablesAndAccruedExpenses42.18M22.78M19.58M16.66M
CurrentAccruedExpenses18.89M8.63M13.77M7.34M
InterestPayable1.80M0.00
Payables23.30M14.14M5.81M9.32M
AccountsPayable23.30M14.14M5.81M9.32M
TotalAssets132.68M143.89M401.07M414.13M
TotalNonCurrentAssets112.12M124.10M367.56M355.03M
OtherNonCurrentAssets23.10M26.93M38.16M17.91M
GoodwillAndOtherIntangibleAssets16.59M18.35M240.69M246.49M
OtherIntangibleAssets9.25M11.00M120.99M123.19M
Goodwill7.35M7.35M119.69M123.30M
NetPPE72.43M78.82M88.72M90.62M
AccumulatedDepreciation-32.87M-27.28M-20.33M-14.78M
GrossPPE105.30M106.10M109.05M105.40M
Leases73.21M73.21M70.11M71.47M
ConstructionInProgress0.0021.00K3.66M2.05M
OtherProperties24.92M25.08M27.49M11.39M
MachineryFurnitureEquipment7.16M7.78M7.78M7.97M
BuildingsAndImprovements0.0012.51M
Properties0.000.000.000.00
CurrentAssets20.56M19.79M33.50M59.10M
OtherCurrentAssets261.00K329.00K1.05M2.00K
PrepaidAssets596.00K1.37M6.21M7.08M
Inventory5.41M5.75M5.31M9.55M
Receivables13.56M12.12M6.97M5.23M
NotesReceivable0.002.07M2.51M2.49M
AccountsReceivable13.56M10.05M4.45M2.75M
AllowanceForDoubtfulAccountsReceivable-6.29M-5.84M-1.79M-283.00K
GrossAccountsReceivable19.85M15.88M6.24M3.03M
CashCashEquivalentsAndShortTermInvestments738.00K227.00K13.97M37.24M
CashAndCashEquivalents738.00K227.00K13.97M37.24M
Line Item2024-12-312023-12-312022-12-312021-12-31
FreeCashFlow-6.56M-42.73M-143.11M-116.30M
RepurchaseOfCapitalStock0.00
RepaymentOfDebt-17.52M-16.81M0.00-5.00M
IssuanceOfDebt3.62M2.00M85.69M5.00M
IssuanceOfCapitalStock6.00M21.89M36.52M83.40M
CapitalExpenditure-161.00K-4.05M-5.24M-6.20M
InterestPaidSupplementalData144.00K1.07M0.00146.00K
IncomeTaxPaidSupplementalData0.000.00
EndCashPosition10.98M10.16M28.80M52.08M
BeginningCashPosition10.16M28.80M52.08M69.51M
ChangesInCash814.00K-18.64M-23.27M-17.44M
FinancingCashFlow6.70M24.09M119.84M98.56M
CashFlowFromContinuingFinancingActivities6.70M24.09M119.84M98.56M
NetOtherFinancingCharges-459.00K-1.65M-3.23M9.14M
ProceedsFromStockOptionExercised15.06M18.67M862.00K6.02M
NetPreferredStockIssuance0.00
PreferredStockIssuance0.00
NetCommonStockIssuance6.00M21.89M36.52M83.40M
CommonStockPayments0.00
CommonStockIssuance6.00M21.89M36.52M83.40M
NetIssuancePaymentsOfDebt-13.90M-14.81M85.69M0.00
NetShortTermDebtIssuance-13.90M-14.81M39.20M0.00
ShortTermDebtPayments-17.52M-16.81M0.00-5.00M
ShortTermDebtIssuance3.62M2.00M39.20M5.00M
NetLongTermDebtIssuance17.37M46.49M
LongTermDebtIssuance17.37M46.49M
InvestingCashFlow514.00K-4.05M-5.24M-5.90M
CashFlowFromContinuingInvestingActivities514.00K-4.05M-5.24M-5.90M
NetOtherInvestingChanges2.17M300.00K
NetBusinessPurchaseAndSale-1.50M0.000.00
SaleOfBusiness0.00
PurchaseOfBusiness-1.50M0.00
NetIntangiblesPurchaseAndSale0.00-3.00M0.00
PurchaseOfIntangibles0.00-3.00M0.00
CapitalExpenditureReported-161.00K-1.05M-5.24M-6.20M
OperatingCashFlow-6.40M-38.69M-137.88M-110.10M
CashFlowFromContinuingOperatingActivities-6.40M-38.69M-137.88M-110.10M
ChangeInWorkingCapital22.20M3.25M-17.98M-11.08M
ChangeInOtherWorkingCapital606.00K1.80M688.00K-7.03M
ChangeInPayablesAndAccruedExpense18.37M3.54M1.76M1.21M
ChangeInAccruedExpense9.13M-4.96M4.71M-1.80M
ChangeInPayable9.24M8.50M-2.95M3.01M
ChangeInAccountPayable9.24M8.50M-2.95M3.01M
ChangeInPrepaidAssets905.00K5.61M49.00K3.07M
ChangeInInventory6.28M-865.00K-16.89M-6.42M
ChangeInReceivables-3.97M-6.83M-3.58M-1.91M
ChangesInAccountReceivables-3.97M-6.83M-3.58M-1.91M
OtherNonCashItems5.39M-92.31M-123.67M-33.19M
StockBasedCompensation11.73M15.02M15.86M40.01M
ProvisionandWriteOffofAssets271.00K2.56M1.88M298.00K
AssetImpairmentCharge466.00K225.53M4.51M0.00
DeferredTax0.00-1.00K-1.35M
DeferredIncomeTax0.00-1.00K-1.35M
DepreciationAmortizationDepletion7.92M9.32M9.44M8.82M
DepreciationAndAmortization7.92M9.32M9.44M8.82M
AmortizationCashFlow1.75M2.19M
AmortizationOfIntangibles1.75M2.19M
Depreciation6.17M7.13M
OperatingGainsLosses3.51M-5.76M-42.11M-13.48M
GainLossOnInvestmentSecurities-398.00K-5.76M-42.11M-13.48M
GainLossOnSaleOfBusiness0.00
NetIncomeFromContinuingOperations-57.89M-196.29M14.19M-100.12M
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Public Trades for CELU
Date User Asset Broker Type Position Size Entry Price Patterns